Evidence map›Paper›PMID 36011296›Full record

ArticleGenes2022

Ana Kosac, Jovan Pesovic, Lana Radenkovic, Milos Brkusanin, Nemanja Radovanovic, Marina Djurisic, Danijela Radivojevic, Jelena Mladenovic, Slavica Ostojic, Gordana Kovacevic and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Ana KosacDepartment of Neurology, Clinic of Neurology and Psychiatry for Children and Youth, 11000 Belgrade, Serbia.
Jovan PesovicCentre for Human Molecular Genetics, Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia.
Lana RadenkovicCentre for Human Molecular Genetics, Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia.
Milos BrkusaninCentre for Human Molecular Genetics, Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-4316-9231
Nemanja RadovanovicCentre for Human Molecular Genetics, Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia.
Marina DjurisicLaboratory of Medical Genetics, Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic", 11000 Belgrade, Serbia.
Danijela RadivojevicLaboratory of Medical Genetics, Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic", 11000 Belgrade, Serbia.ORCID 0000-0003-0334-3896
Jelena MladenovicDepartment of Neurology, Clinic of Neurology and Psychiatry for Children and Youth, 11000 Belgrade, Serbia.
Slavica OstojicDepartment of Neurology, Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic", 11000 Belgrade, Serbia.ORCID 0000-0002-8979-0445
Gordana KovacevicDepartment of Neurology, Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic", 11000 Belgrade, Serbia.
Ruzica KravljanacDepartment of Neurology, Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic", 11000 Belgrade, Serbia.
Dusanka Savic PavicevicCentre for Human Molecular Genetics, Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-2079-4077
Vedrana Milic RasicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
University of Belgrade · RSInstitute of Public Health of Serbia · RSUniversity Children's Hospital, Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical course variability in Duchenne muscular dystrophy (DMD) is partially explained by the mutation location in the

methodsSNPs in

resultsPatients on glucocorticoid corticosteroid (GC) therapy experienced LoA one year later (

conclusionsThe modifying effect of

Indexed as

Muscular Dystrophy, DuchenneCD40 AntigensGenes, ModifierGlucocorticoidsHumansLatent TGF-beta Binding ProteinsOsteopontinPolymorphism, Single NucleotideSerbiaCD40 AntigensGlucocorticoidsLatent TGF-beta Binding ProteinsLTBP4 protein, humanOsteopontinSPP1 protein, humanCD40Duchenne muscular dystrophyLTBP4single-nucleotide polymorphismsSPP1

Identifiers

PMID36011296
PMCPMC9407083
OpenAlexW4289745482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.